 Mark Roback
Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Conscious Sedation | 20 | 2021 | 79 | 3.880 |
Why?
| | Emergency Service, Hospital | 30 | 2021 | 1848 | 2.390 |
Why?
| | Ketamine | 17 | 2021 | 92 | 2.120 |
Why?
| | Hypnotics and Sedatives | 12 | 2020 | 136 | 1.910 |
Why?
| | Anesthesia | 3 | 2022 | 120 | 1.510 |
Why?
| | Laryngismus | 3 | 2022 | 6 | 1.010 |
Why?
| | Laryngoscopy | 2 | 2019 | 97 | 0.860 |
Why?
| | Anesthetics, Dissociative | 9 | 2021 | 29 | 0.810 |
Why?
| | Intubation, Intratracheal | 2 | 2019 | 225 | 0.790 |
Why?
| | Analgesia | 5 | 2018 | 81 | 0.770 |
Why?
| | Autism Spectrum Disorder | 2 | 2021 | 324 | 0.710 |
Why?
| | Airway Management | 1 | 2019 | 63 | 0.640 |
Why?
| | Emergency Medical Services | 3 | 2021 | 587 | 0.610 |
Why?
| | Anesthesiology | 1 | 2017 | 39 | 0.610 |
Why?
| | Intubation, Gastrointestinal | 1 | 2017 | 61 | 0.600 |
Why?
| | Child, Preschool | 29 | 2021 | 9448 | 0.590 |
Why?
| | Gastrostomy | 1 | 2017 | 93 | 0.580 |
Why?
| | Child | 38 | 2022 | 19033 | 0.570 |
Why?
| | Liability, Legal | 1 | 2016 | 39 | 0.560 |
Why?
| | Anti-Allergic Agents | 1 | 2016 | 41 | 0.560 |
Why?
| | Gastric Bypass | 1 | 2017 | 93 | 0.560 |
Why?
| | Fasting | 4 | 2019 | 256 | 0.550 |
Why?
| | Infant | 27 | 2021 | 8254 | 0.510 |
Why?
| | Patient Transfer | 1 | 2016 | 143 | 0.490 |
Why?
| | Hospitalization | 4 | 2017 | 1778 | 0.470 |
Why?
| | Emergency Treatment | 4 | 2021 | 110 | 0.450 |
Why?
| | Hypersensitivity | 1 | 2016 | 270 | 0.440 |
Why?
| | Vomiting | 6 | 2020 | 123 | 0.360 |
Why?
| | Atropine | 2 | 2010 | 32 | 0.350 |
Why?
| | Pediatrics | 5 | 2015 | 980 | 0.340 |
Why?
| | Adolescent | 24 | 2021 | 18364 | 0.320 |
Why?
| | Humans | 52 | 2022 | 118257 | 0.310 |
Why?
| | Midazolam | 4 | 2018 | 49 | 0.290 |
Why?
| | Propofol | 2 | 2017 | 49 | 0.280 |
Why?
| | Anesthetics, Intravenous | 2 | 2017 | 34 | 0.260 |
Why?
| | Premedication | 1 | 2004 | 40 | 0.250 |
Why?
| | Etomidate | 2 | 2016 | 8 | 0.250 |
Why?
| | Male | 28 | 2021 | 57476 | 0.250 |
Why?
| | Bradycardia | 1 | 2004 | 49 | 0.240 |
Why?
| | Consensus | 4 | 2019 | 533 | 0.240 |
Why?
| | Intussusception | 1 | 2003 | 27 | 0.240 |
Why?
| | Enema | 1 | 2003 | 39 | 0.240 |
Why?
| | Orthopedic Procedures | 1 | 2006 | 225 | 0.230 |
Why?
| | Emergency Medicine | 2 | 2004 | 236 | 0.230 |
Why?
| | Prospective Studies | 10 | 2021 | 6443 | 0.220 |
Why?
| | Terminology as Topic | 2 | 2017 | 199 | 0.220 |
Why?
| | Administration, Intravenous | 3 | 2018 | 135 | 0.210 |
Why?
| | Infant, Newborn | 9 | 2021 | 5230 | 0.210 |
Why?
| | Respiratory Tract Diseases | 2 | 2005 | 142 | 0.200 |
Why?
| | Female | 24 | 2021 | 61262 | 0.190 |
Why?
| | Retrospective Studies | 12 | 2021 | 12929 | 0.190 |
Why?
| | Excitatory Amino Acid Antagonists | 2 | 2018 | 90 | 0.190 |
Why?
| | Hospitals, Pediatric | 5 | 2021 | 504 | 0.190 |
Why?
| | Government Regulation | 1 | 2020 | 45 | 0.190 |
Why?
| | Epiglottitis | 1 | 2000 | 4 | 0.180 |
Why?
| | Fasciitis, Necrotizing | 1 | 2000 | 9 | 0.180 |
Why?
| | Preoperative Care | 2 | 2020 | 332 | 0.180 |
Why?
| | Administration, Intranasal | 2 | 2018 | 79 | 0.180 |
Why?
| | Racepinephrine | 1 | 2019 | 1 | 0.180 |
Why?
| | Infant Mortality | 1 | 2000 | 93 | 0.180 |
Why?
| | Croup | 1 | 2019 | 22 | 0.170 |
Why?
| | Chickenpox | 1 | 2000 | 100 | 0.170 |
Why?
| | Depressive Disorder, Treatment-Resistant | 1 | 2018 | 4 | 0.170 |
Why?
| | Endpoint Determination | 1 | 2018 | 69 | 0.160 |
Why?
| | Oral and Maxillofacial Surgeons | 1 | 2018 | 1 | 0.160 |
Why?
| | Meningococcal Infections | 1 | 1998 | 20 | 0.160 |
Why?
| | Protein C | 1 | 1998 | 42 | 0.160 |
Why?
| | Deep Sedation | 1 | 2017 | 11 | 0.160 |
Why?
| | Patient Outcome Assessment | 1 | 2018 | 123 | 0.150 |
Why?
| | Respiratory Sounds | 1 | 1998 | 119 | 0.150 |
Why?
| | Bronchodilator Agents | 1 | 2019 | 251 | 0.150 |
Why?
| | Reference Standards | 1 | 2017 | 174 | 0.150 |
Why?
| | Radiography, Thoracic | 1 | 1998 | 163 | 0.150 |
Why?
| | Checklist | 1 | 2017 | 81 | 0.150 |
Why?
| | Ranitidine | 1 | 2016 | 13 | 0.150 |
Why?
| | Comorbidity | 1 | 2021 | 1516 | 0.140 |
Why?
| | Diphenhydramine | 1 | 2016 | 29 | 0.140 |
Why?
| | Cohort Studies | 6 | 2020 | 5078 | 0.140 |
Why?
| | Nitrous Oxide | 1 | 2016 | 12 | 0.140 |
Why?
| | Advisory Committees | 1 | 2017 | 212 | 0.140 |
Why?
| | Hematocele | 1 | 1996 | 1 | 0.140 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 539 | 0.140 |
Why?
| | Splenic Rupture | 1 | 1996 | 5 | 0.140 |
Why?
| | Methylprednisolone | 1 | 2016 | 84 | 0.140 |
Why?
| | Feasibility Studies | 1 | 2019 | 746 | 0.140 |
Why?
| | Anxiety | 1 | 2022 | 845 | 0.140 |
Why?
| | Patient Safety | 2 | 2018 | 281 | 0.140 |
Why?
| | Shock, Septic | 1 | 1998 | 187 | 0.140 |
Why?
| | Scrotum | 1 | 1996 | 25 | 0.140 |
Why?
| | Bronchiolitis | 1 | 1997 | 83 | 0.130 |
Why?
| | Dexmedetomidine | 1 | 2016 | 52 | 0.130 |
Why?
| | Epinephrine | 1 | 2016 | 166 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 1937 | 0.130 |
Why?
| | Research Design | 2 | 2018 | 961 | 0.130 |
Why?
| | Edema | 1 | 1996 | 124 | 0.130 |
Why?
| | Respiration, Artificial | 1 | 2019 | 543 | 0.130 |
Why?
| | Standard of Care | 1 | 2015 | 63 | 0.130 |
Why?
| | Haemophilus influenzae | 1 | 1994 | 50 | 0.130 |
Why?
| | Double-Blind Method | 3 | 2016 | 1683 | 0.120 |
Why?
| | Risk Factors | 10 | 2021 | 8958 | 0.120 |
Why?
| | Canada | 4 | 2018 | 338 | 0.120 |
Why?
| | Research | 1 | 2017 | 406 | 0.120 |
Why?
| | Blood | 1 | 1994 | 97 | 0.120 |
Why?
| | Child Behavior Disorders | 1 | 2015 | 129 | 0.120 |
Why?
| | Practice Guidelines as Topic | 4 | 2019 | 1433 | 0.120 |
Why?
| | Clinical Trials as Topic | 1 | 2018 | 964 | 0.120 |
Why?
| | Spleen | 1 | 1996 | 504 | 0.120 |
Why?
| | Treatment Outcome | 5 | 2019 | 9319 | 0.110 |
Why?
| | Streptococcus pneumoniae | 1 | 1994 | 141 | 0.110 |
Why?
| | Bacteremia | 1 | 1994 | 161 | 0.110 |
Why?
| | Wounds and Injuries | 1 | 2000 | 697 | 0.110 |
Why?
| | Wounds, Nonpenetrating | 1 | 1996 | 279 | 0.110 |
Why?
| | Patient-Centered Care | 1 | 2017 | 493 | 0.110 |
Why?
| | United States | 4 | 2021 | 12491 | 0.110 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 789 | 0.110 |
Why?
| | Oxygen | 1 | 1997 | 854 | 0.110 |
Why?
| | Analgesics | 2 | 2005 | 159 | 0.100 |
Why?
| | Patient Readmission | 1 | 1997 | 631 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2019 | 2855 | 0.100 |
Why?
| | Infusions, Intravenous | 3 | 2009 | 379 | 0.100 |
Why?
| | Incidence | 7 | 2017 | 2413 | 0.100 |
Why?
| | Clinical Protocols | 2 | 2015 | 234 | 0.100 |
Why?
| | Patient Discharge | 1 | 1997 | 791 | 0.090 |
Why?
| | Anesthesia Recovery Period | 2 | 2009 | 10 | 0.090 |
Why?
| | Glycopyrrolate | 1 | 2010 | 2 | 0.090 |
Why?
| | Adjuvants, Anesthesia | 1 | 2010 | 9 | 0.090 |
Why?
| | Adult | 6 | 2019 | 31325 | 0.090 |
Why?
| | Muscarinic Antagonists | 1 | 2010 | 25 | 0.090 |
Why?
| | Injections, Intramuscular | 2 | 2009 | 116 | 0.090 |
Why?
| | Quality Improvement | 1 | 2017 | 962 | 0.090 |
Why?
| | Neck Pain | 1 | 2009 | 24 | 0.090 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2009 | 16 | 0.090 |
Why?
| | Fentanyl | 2 | 2012 | 70 | 0.090 |
Why?
| | Neck Injuries | 1 | 2009 | 20 | 0.090 |
Why?
| | Diabetic Ketoacidosis | 2 | 2002 | 168 | 0.090 |
Why?
| | Time Factors | 4 | 2020 | 6368 | 0.080 |
Why?
| | Psychomotor Agitation | 1 | 2009 | 71 | 0.080 |
Why?
| | Ondansetron | 1 | 2008 | 9 | 0.080 |
Why?
| | Antiemetics | 1 | 2008 | 34 | 0.080 |
Why?
| | Respiratory System | 1 | 2009 | 141 | 0.080 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2015 | 760 | 0.070 |
Why?
| | Postoperative Complications | 1 | 2017 | 2230 | 0.070 |
Why?
| | Age Factors | 5 | 2021 | 2990 | 0.070 |
Why?
| | Colorado | 3 | 2005 | 4178 | 0.070 |
Why?
| | Foeniculum | 1 | 2005 | 1 | 0.070 |
Why?
| | Plant Poisoning | 1 | 2005 | 9 | 0.070 |
Why?
| | Methemoglobinemia | 1 | 2005 | 13 | 0.070 |
Why?
| | Infusions, Parenteral | 1 | 2005 | 37 | 0.070 |
Why?
| | Guideline Adherence | 2 | 2019 | 520 | 0.060 |
Why?
| | Reflex | 1 | 2004 | 64 | 0.060 |
Why?
| | Chi-Square Distribution | 3 | 2010 | 524 | 0.060 |
Why?
| | Respiration Disorders | 1 | 2004 | 66 | 0.060 |
Why?
| | Logistic Models | 4 | 2016 | 1896 | 0.060 |
Why?
| | Respiratory Aspiration | 2 | 2018 | 33 | 0.060 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 964 | 0.050 |
Why?
| | Hypocapnia | 1 | 2001 | 5 | 0.050 |
Why?
| | Injections, Intravenous | 2 | 2013 | 209 | 0.050 |
Why?
| | Blood Urea Nitrogen | 1 | 2001 | 59 | 0.050 |
Why?
| | Recurrence | 1 | 2003 | 971 | 0.050 |
Why?
| | Brain Edema | 1 | 2001 | 61 | 0.050 |
Why?
| | Infant Equipment | 1 | 2000 | 7 | 0.050 |
Why?
| | Fever | 1 | 2021 | 283 | 0.050 |
Why?
| | Respiratory Aspiration of Gastric Contents | 1 | 2019 | 1 | 0.050 |
Why?
| | Corneal Diseases | 1 | 2000 | 36 | 0.050 |
Why?
| | Streptococcus pyogenes | 1 | 2000 | 35 | 0.040 |
Why?
| | United States Food and Drug Administration | 1 | 2020 | 174 | 0.040 |
Why?
| | Risk Assessment | 3 | 2018 | 3043 | 0.040 |
Why?
| | Transportation of Patients | 1 | 2000 | 49 | 0.040 |
Why?
| | Eye Injuries | 1 | 2000 | 46 | 0.040 |
Why?
| | Case-Control Studies | 3 | 2010 | 3156 | 0.040 |
Why?
| | Delphi Technique | 1 | 2019 | 163 | 0.040 |
Why?
| | Cholinergic Antagonists | 2 | 2009 | 28 | 0.040 |
Why?
| | Length of Stay | 1 | 2003 | 1027 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 1857 | 0.040 |
Why?
| | American Dental Association | 1 | 2018 | 6 | 0.040 |
Why?
| | Prothrombin | 1 | 1998 | 21 | 0.040 |
Why?
| | Benzodiazepines | 2 | 2009 | 123 | 0.040 |
Why?
| | Hypoxia | 1 | 2004 | 957 | 0.040 |
Why?
| | Anesthesiologists | 1 | 2018 | 15 | 0.040 |
Why?
| | Survival | 1 | 1998 | 39 | 0.040 |
Why?
| | Platelet Count | 1 | 1998 | 81 | 0.040 |
Why?
| | Radiology, Interventional | 1 | 2018 | 28 | 0.040 |
Why?
| | Hematocrit | 1 | 1998 | 89 | 0.040 |
Why?
| | Acute Disease | 2 | 2002 | 933 | 0.040 |
Why?
| | Resuscitation | 1 | 2000 | 222 | 0.040 |
Why?
| | Triage | 1 | 2000 | 203 | 0.040 |
Why?
| | Hypoglycemia | 1 | 2002 | 401 | 0.040 |
Why?
| | Leukocyte Count | 1 | 1998 | 303 | 0.040 |
Why?
| | Fibrinogen | 1 | 1998 | 150 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2020 | 585 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2000 | 1787 | 0.040 |
Why?
| | Hospitals, General | 1 | 2016 | 19 | 0.040 |
Why?
| | Physical Examination | 1 | 2018 | 242 | 0.040 |
Why?
| | Multivariate Analysis | 3 | 2010 | 1469 | 0.040 |
Why?
| | Endotoxins | 1 | 1998 | 234 | 0.040 |
Why?
| | Rabbits | 1 | 1998 | 779 | 0.040 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2018 | 499 | 0.030 |
Why?
| | Staphylococcus aureus | 1 | 2000 | 394 | 0.030 |
Why?
| | Hemoglobins | 1 | 1998 | 318 | 0.030 |
Why?
| | Diagnostic Errors | 1 | 1997 | 162 | 0.030 |
Why?
| | Trauma Severity Indices | 1 | 1996 | 122 | 0.030 |
Why?
| | Societies, Medical | 1 | 2019 | 701 | 0.030 |
Why?
| | Remission Induction | 1 | 2015 | 246 | 0.030 |
Why?
| | Spectrophotometry | 1 | 1994 | 52 | 0.030 |
Why?
| | Heart Diseases | 1 | 1998 | 340 | 0.030 |
Why?
| | Thrombosis | 1 | 1998 | 303 | 0.030 |
Why?
| | Odds Ratio | 1 | 2017 | 993 | 0.030 |
Why?
| | Cardiovascular Diseases | 1 | 2005 | 1795 | 0.030 |
Why?
| | Heart Arrest | 1 | 2016 | 291 | 0.030 |
Why?
| | Databases, Factual | 1 | 2017 | 1196 | 0.030 |
Why?
| | Algorithms | 1 | 2019 | 1522 | 0.030 |
Why?
| | Young Adult | 2 | 2017 | 10731 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 1996 | 1379 | 0.030 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2010 | 13 | 0.020 |
Why?
| | Switzerland | 1 | 2009 | 27 | 0.020 |
Why?
| | Pain | 1 | 2015 | 736 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2002 | 3358 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 4522 | 0.020 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2008 | 68 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 1998 | 3676 | 0.020 |
Why?
| | Registries | 1 | 2015 | 1806 | 0.020 |
Why?
| | Fractures, Bone | 1 | 2012 | 376 | 0.020 |
Why?
| | Documentation | 1 | 2008 | 170 | 0.020 |
Why?
| | Contraindications | 1 | 2006 | 86 | 0.020 |
Why?
| | Methylene Blue | 1 | 2005 | 24 | 0.020 |
Why?
| | Cyanosis | 1 | 2005 | 17 | 0.020 |
Why?
| | Foodborne Diseases | 1 | 2005 | 49 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2005 | 817 | 0.010 |
Why?
| | Bicarbonates | 1 | 2001 | 44 | 0.010 |
Why?
| | Random Allocation | 1 | 2001 | 344 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2000 | 324 | 0.010 |
Why?
| | Fluorescein Angiography | 1 | 2000 | 103 | 0.010 |
Why?
| | Drug Interactions | 1 | 2000 | 351 | 0.010 |
Why?
| | Reference Values | 1 | 2000 | 770 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2001 | 230 | 0.010 |
Why?
| | Visual Acuity | 1 | 2000 | 273 | 0.010 |
Why?
| | Socioeconomic Factors | 1 | 2002 | 1121 | 0.010 |
Why?
| | Sex Factors | 1 | 2002 | 1765 | 0.010 |
Why?
| | Animals | 1 | 1998 | 33152 | 0.010 |
Why?
| | Mental Disorders | 1 | 2002 | 935 | 0.010 |
Why?
|
|
Roback's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|